Ala-Opas M - Search Results

1

Bladder management in persons with spinal cord lesion.

Dahlberg A, Perttilä I, Wuokko E, Ala-Opas M. Dahlberg A, et al. Spinal Cord. 2004 Dec;42(12):694-8. doi: 10.1038/sj.sc.3101650. Spinal Cord. 2004. PMID: 15365573

2

Laparoscopic radical prostatectomy: surgical, oncological and functional outcomes.

Nisen H, Perttilä I, Ranta-Knuuttila T, Ala-Opas M, Sankila A, Taari K. Nisen H, et al. Scand J Urol Nephrol. 2008;42(1):29-34. doi: 10.1080/00365590701561879. Epub 2007 Sep 11. Scand J Urol Nephrol. 2008. PMID: 17853030

3

Advanced prostate cancer treated with intermittent or continuous androgen deprivation in the randomised FinnProstate Study VII: quality of life and adverse effects.

Salonen AJ, Taari K, Ala-Opas M, Viitanen J, Lundstedt S, Tammela TL; FinnProstate Group. Salonen AJ, et al. Among authors: ala opas m. Eur Urol. 2013 Jan;63(1):111-20. doi: 10.1016/j.eururo.2012.07.040. Epub 2012 Jul 27. Eur Urol. 2013. PMID: 22857983 Clinical Trial.

4

Laparoskopiasta on tullut urologian rutiinia--ensimmäiset 178 leikkausta HYKS:ssa.

Nisen H, Perttilä I, Juusela H, Ala-Opas M, Taari K. Nisen H, et al. Duodecim. 2006;122(10):1182-7. Duodecim. 2006. PMID: 16863025 Finnish. No abstract available.

5

Adenocarcinoma in isolated rectal bladder after treatment of bladder exstrophy.

Giordano S, Taskinen S, Sankila A, Ala-Opas M. Giordano S, et al. Scand J Urol Nephrol. 2008;42(4):392-4. doi: 10.1080/00365590701871575. Scand J Urol Nephrol. 2008. PMID: 19230174

6

Hybrid laser treatment compared with transurethral resection of the prostate for symptomatic bladder outlet obstruction caused by a large benign prostate: a prospective, randomized trial with a 6-month follow-up.

Tuhkanen K, Heino A, Alaopas M. Tuhkanen K, et al. BJU Int. 1999 Nov;84(7):805-9. doi: 10.1046/j.1464-410x.1999.00316.x. BJU Int. 1999. PMID: 10532976 Clinical Trial.

7

Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.

Tuhkanen K, Heino A, Aaltomaa S, Ala-Opas M. Tuhkanen K, et al. Scand J Urol Nephrol. 2003;37(6):487-93. doi: 10.1080/00365590310015769. Scand J Urol Nephrol. 2003. PMID: 14675922 Clinical Trial.

8

Treatment of prostate cancer with Ad5/3Delta24hCG allows non-invasive detection of the magnitude and persistence of virus replication in vivo.

Rajecki M, Kanerva A, Stenman UH, Tenhunen M, Kangasniemi L, Särkioja M, Ala-Opas MY, Alfthan H, Sankila A, Rintala E, Desmond RA, Hakkarainen T, Hemminki A. Rajecki M, et al. Mol Cancer Ther. 2007 Feb;6(2):742-51. doi: 10.1158/1535-7163.MCT-06-0403. Mol Cancer Ther. 2007. PMID: 17308070

9

Evaluation of immediate and late results of transurethral resection of the prostate.

Ala-Opas MY, Aitola PT, Metsola TE. Ala-Opas MY, et al. Scand J Urol Nephrol. 1993;27(2):235-9. doi: 10.3109/00365599309181256. Scand J Urol Nephrol. 1993. PMID: 7688910

10

Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: a post hoc analysis of the randomized FinnProstate Study VII.

Salonen AJ, Taari K, Ala-Opas M, Sankila A, Viitanen J, Lundstedt S, Tammela TL; Finnprostate Group. Salonen AJ, et al. Among authors: ala opas m. Scand J Urol. 2014 Dec;48(6):513-22. doi: 10.3109/21681805.2014.901410. Epub 2014 Mar 31. Scand J Urol. 2014. PMID: 24679247 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters